The Hemorrhagic Fever: Ebola and Other Viruses
Abstract
Presently, Ebola epidemic in West Africa emphasizes an immediate need to update management guidelines of viral hemorrhagic fever and develop new vaccines and treatments. Already, there are reports of an experimental monoclonal antibody being prepared and administered in two American healthcare workers who recently acquired Ebola virus infection in Liberia.1 The World Health Organization (WHO) is closely monitoring the evolving Ebola outbreak in Guinea, Liberia, and Sierra Leone and has now declared public health emergency…
Additional Files
Published
Issue
Section
License
Copyright (c) 2024 Pakistan Journal of Medicine and Dentistry

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/